Feasibility of radical cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei of appendiceal origin

Scandinavian Journal of Surgery

Volumn 102, Issue 3, 2013, Pages 145-151

  Jarvinen P ^a   Ristimaki A ^b,c,d   Kantonen, J ^b,c   Lepistö, Anna ^b,e  

^a KANTA HÄME CENTRAL HOSPITAL   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

^d UNIVERSITY OF HELSINKI   (Finland)

^e Surgical Hospital   (Finland)

Author keywords

Appendiceal; Hyperthermic intraperitoneal chemotherapy; Mucinous neoplasm; Peritoneal; Peritonectomy; Sugarbaker procedure

Indexed keywords

ANTINEOPLASTIC ANTIBIOTIC; MITOMYCIN;

ADULT; AGED; CLINICAL TRIAL; FEASIBILITY STUDY; FEMALE; FOLLOW UP; HUMAN; HYPERTHERMIC THERAPY; MALE; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PERITONEAL NEOPLASMS; PERITONEUM; PROSPECTIVE STUDY; PSEUDOMYXOMA PERITONEI; SURGERY; TREATMENT OUTCOME; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTIBIOTICS, ANTINEOPLASTIC; COMBINED MODALITY THERAPY; FEASIBILITY STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTHERMIA, INDUCED; MALE; MIDDLE AGED; MITOMYCIN; PERITONEAL NEOPLASMS; PERITONEUM; PROSPECTIVE STUDIES; PSEUDOMYXOMA PERITONEI; TREATMENT OUTCOME;

EID: 84902675833     PISSN: 14574969     EISSN: None     Source Type: Journal    
DOI: 10.1177/1457496913490463     Document Type: Article

References (30)

1. Smeenk RM, van Velthuysen ML, Verwaal VJ et al: Appendiceal neoplasms and pseudomyxoma peritonei: A population based study. Eur J Surg Oncol 2008;34:196-201.
2. Sugarbaker PH: Pseudomyxoma peritonei. A cancer whose biology is characterized by a redistribution phenomenon. Ann Surg 1994;219:109-111.
3. Szych C, Staebler A, Connolly DC et al: Molecular genetic evidence supporting the clonality and appendiceal origin of Pseudomyxoma peritonei in women. Am J Pathol 1999;154:1849-1855.
4. Mukherjee A, Parvaiz A, Cecil TD et al: Pseudomyxoma peritonei usually originates from the appendix: A review of the evidence. Eur J Gynaecol Oncol 2004;25:411-414.
5. Jarvinen P, Lepisto A: Clinical presentation of pseudomyxoma peritonei. Scand J Surg 2010;99:213-216.
6. Panarelli NC, Yantiss RK: Mucinous neoplasms of the appendix and peritoneum. Arch Pathol Lab Med 2011;135:1261-1268.
7. Misdraji J, Yantiss RK, Graeme-Cook FM et al: Appendiceal mucinous neoplasms: A clinicopathologic analysis of 107 cases. Am J Surg Pathol 2003;27:1089-1103.
8. Ronnett BM, Zahn CM, Kurman RJ et al: Disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis. A clinicopathologic analysis of 109 cases with emphasis on distinguishing pathologic features, site of origin, prognosis, and relationship to "pseudomyxoma peritonei." Am J Surg Pathol 1995;19:1390-1408.
9. Bradley RF, Stewart JH 4th, Russell GB et al: Pseudomyxoma peritonei of appendiceal origin: A clinicopathologic analysis of 101 patients uniformly treated at a single institution, with literature review. Am J Surg Pathol 2006;30:551-559.
10. Pai RK, Longacre TA: Appendiceal mucinous tumors and pseudomyxoma peritonei: Histologic features, diagnostic problems, and proposed classification. Adv Anat Pathol 2005;12: 291-311.
11. Bosman F, Carneiro F, Hruban R et al (eds): WHO classification of tumours of the digestive system. Lyon, IARC, 2010.
12. Jarvinen P, Jarvinen HJ, Lepisto A: Survival of patients with pseudomyxoma peritonei treated by serial debulking. Colorectal Dis 2010;12:868-872.
13. Gough DB, Donohue JH, Schutt AJ et al: Pseudomyxoma peritonei. Long-term patient survival with an aggressive regional approach. Ann Surg 1994;219:112-119.
14. Miner TJ, Shia J, Jaques DP et al: Long-term survival following treatment of pseudomyxoma peritonei: An analysis of surgical therapy. Ann Surg 2005;241:300-308.
15. Youssef H, Newman C, Chandrakumaran K et al: Operative findings, early complications, and long-term survival in 456 patients with pseudomyxoma peritonei syndrome of appendiceal origin. Dis Colon Rectum 2011;54:293-299.
16. Vaira M, Cioppa T, De Marco G et al: Management of pseudomyxoma peritonei by cytoreduction+HIPEC (hyperthermic intraperitoneal chemotherapy): Results analysis of a twelve-year experience. In Vivo 2009;23:639-644.
17. Smeenk RM, Bruin SC, van Velthuysen ML et al: Pseudomyxoma peritonei. Curr Probl Surg 2008;45:527-575.
18. Moran BJ: Decision-making and technical factors account for the learning curve in complex surgery. J Public Health (Oxf) 2006;28:375-378.
19. Sugarbaker PH: Peritonectomy procedures. Cancer Treat Res 1996;82:235-253.
20. Sugarbaker PH: Carcinomatosis from gastrointestinal cancer. Ann Med 2004;36:9-22.
21. Sugarbaker PH, Chang D: Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy. Ann Surg Oncol 1999;6:727-731.
22. Stephens AD, Alderman R, Chang D et al: Morbidity and mortality analysis of 200 treatments with cytoreductive surgery and hyperthermic intraoperative intraperitoneal chemotherapy using the coliseum technique. Ann Surg Oncol 1999;6:790-796.
23. Rout S, Renehan AG, Parkinson MF et al: Treatments and outcomes of peritoneal surface tumors through a centralized national service (United kingdom). Dis Colon Rectum 2009;52:1705-1714.
24. Deraco M, Baratti D, Inglese MG et al: Peritonectomy and intraperitoneal hyperthermic perfusion (IPHP): A strategy that has confirmed its efficacy in patients with pseudomyxoma peritonei. Ann Surg Oncol 2004;11:393-398.
25. Portilla AG, Shigeki K, Dario B et al: The intraoperative staging systems in the management of peritoneal surface malignancy. J Surg Oncol 2008;98:228-231.
26. Verwaal VJ, van Tinteren H, van Ruth S et al: Predicting the survival of patients with peritoneal carcinomatosis of colorectal origin treated by aggressive cytoreduction and hyperthermic intraperitoneal chemotherapy. Br J Surg 2004;91:739-746.
27. Smeenk RM, Verwaal VJ, Antonini N et al: Survival analysis of pseudomyxoma peritonei patients treated by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg 2007;245:104-109.
28. Klaver YL, Chua TC, de Hingh IH et al: Outcomes of elderly patients undergoing cytoreductive surgery and perioperative intraperitoneal chemotherapy for colorectal cancer peritoneal carcinomatosis. J Surg Oncol 2012;105:113-118.
29. Baratti D, Kusamura S, Martinetti A et al: Prognostic value of circulating tumor markers in patients with pseudomyxoma peritonei treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol 2007;14: 2300-2308.
30. Alexander-Sefre F, Chandrakumaran K, Banerjee S et al: Elevated tumour markers prior to complete tumour removal in patients with pseudomyxoma peritonei predict early recurrence. Colorectal Dis 2005;7:382-386.